Education
About Us
Working with TipRanks
Follow Us
Seamus Mulligan Insider Profile
4 Followers
Seamus Mulligan, Director at Jazz Pharmaceuticals, holds 1.28M shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 601.73K shares in Emergent Biosolutions (Ticker: EBS). Most recently, Seamus Mulligan Bought ― shares of Jazz Pharmaceuticals on May 13, 2025 for an estimated value of 9.99M.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+12.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Seamus Mulligan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 27, 2020 - May 27, 2021
Return:+55.00%
The most profitable trade made by Seamus Mulligan
Seamus Mulligan's Trading History
Jazz Pharmaceuticals
May 13, 2025
Director
Informative Buy
9.99M
$142.21M
Emergent Biosolutions
Mar 21, 2019
Director
Uninformative Buy
―
$5.16M
List of latest transactions for each holding click on a transaction to see Seamus Mulligan's performance on stock
You May Also Like
Seamus Mulligan insider profile FAQ
What is the percentage of profitable transactions made by Seamus Mulligan?
The percentage of profitable transactions made by Seamus Mulligan is 50%.
What is the average return per transaction made by Seamus Mulligan?
The average return per transaction made by Seamus Mulligan is 12.30%.
What stocks does Seamus Mulligan hold?
Seamus Mulligan holds: JAZZ, EBS stocks.
What was Seamus Mulligan’s latest transaction?
Seamus Mulligan latest transaction was an Informative Buy of $9.99M.
What was Seamus Mulligan's most profitable transaction?
Seamus Mulligan’s most profitable transaction was an Informative Buy of JAZZ stock on May 27, 2020. The return on the trade was 55.00%.
What is Seamus Mulligan's role in Jazz Pharmaceuticals?
Seamus Mulligan's role in Jazz Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.